51152 Comparable Efficacy and Less Dryness with a Novel Cosmetic Regimen When Compared to a Topical Drug Combination of Adapalene 0.1% and Benzoyl Peroxide 2.5% in Subjects with Mild to Moderate Facial Acne - 01/09/24

Doi : 10.1016/j.jaad.2024.07.652

Elizabeth Makino, BS, CCRA, MBA
Allergan Aesthetics, an AbbVie Company

Priscilla Huang, B.A.
Allergan Aesthetics, an AbbVie Company

Olivia Supan, B.A.
Allergan Aesthetics, an AbbVie Company

Cecilia Pak, Ph.D.
SGS Stephens Inc

Rahul Mehta, Ph.D.
Allergan Aesthetics, an AbbVie Company

Il testo completo di questo articolo è disponibile in PDF.

Commercial Support: 100% is sponsored by Allergan Aesthetics, an AbbVie Company.

Esportazione

Vol 91 - N° 3S

P. AB164 - settembre 2024 Ritorno al numero

Articolo precedente

52304 COMORBIDITY PATTERNS IN PATIENTS WITH CHRONIC SKIN DISEASES: VITILIGO
Beatriz Clemente Hernández, Itziar Muelas Rives, Laura Bernal Masferrer, Mariana Claudia Matei, Tamara Gracia Cazaña, Yolanda Gilaberte Calzada

| Articolo seguente

53678 Comparative randomized split face clinical study to assess the efficacy and tolerance of a serum containing Angiopausin and Avène Thermal Spring water in adult women with erythematotelangiectatic rosacea
TERESA NOCERA, Karine BOYER, Gwendal JOSSE, Aurelie VILLARET, Jimmy LE. DIGABEL, Christophe LAUZE, Eleonore GRAVIER, Gautier DOAT, Pierre-Jacques FERRET, Jean-Hilaire SAURAT

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

51152 Comparable Efficacy and Less Dryness with a Novel Cosmetic Regimen When Compared to a Topical Drug Combination of Adapalene 0.1% and Benzoyl Peroxide 2.5% in Subjects with Mild to Moderate Facial Acne - 01/09/24

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL